Somnomed Ltd (AU:SOM) — Market Cap & Net Worth
Market Cap & Net Worth: Somnomed Ltd (SOM)
Somnomed Ltd (AU:SOM) has a market capitalization of $94.56 Million (AU$133.64 Million) as of May 5, 2026. Listed on the AU stock exchange, this Australia-based company holds position #19400 globally and #641 in its home market, demonstrating a -2.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Somnomed Ltd's stock price AU$0.61 by its total outstanding shares 219083253 (219.08 Million). Analyse Somnomed Ltd cash conversion from operations to see how efficiently the company converts income to cash.
Somnomed Ltd Market Cap History: 2015 to 2026
Somnomed Ltd's market capitalization history from 2015 to 2026. Data shows change from $335.65 Million to $94.56 Million (-10.31% CAGR).
Somnomed Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Somnomed Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.07x
Somnomed Ltd's market cap is 1.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $488.44 Million | $44.08 Million | $165.00K | 11.08x | 2960.14x |
| 2017 | $463.00 Million | $49.33 Million | -$3.34 Million | 9.39x | N/A |
| 2018 | $232.90 Million | $52.39 Million | $2.32 Million | 4.45x | 100.53x |
| 2019 | $372.89 Million | $58.89 Million | -$39.39K | 6.33x | N/A |
| 2020 | $311.32 Million | $57.30 Million | -$1.12 Million | 5.43x | N/A |
| 2021 | $348.38 Million | $62.71 Million | -$1.19 Million | 5.56x | N/A |
| 2022 | $191.24 Million | $72.58 Million | -$4.44 Million | 2.63x | N/A |
| 2023 | $77.51 Million | $83.62 Million | -$8.00 Million | 0.93x | N/A |
| 2024 | $71.31 Million | $91.65 Million | -$12.24 Million | 0.78x | N/A |
| 2025 | $119.75 Million | $111.49 Million | -$3.46 Million | 1.07x | N/A |
Competitor Companies of SOM by Market Capitalization
Companies near Somnomed Ltd in the global market cap rankings as of May 5, 2026.
Key companies related to Somnomed Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #145 globally with a market cap of $152.22 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #211 globally with a market cap of $111.32 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #229 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (XETRA:2M6): Ranked #236 globally with a market cap of $101.71 Billion USD ( €87.00 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #145 | Abbott Laboratories | NYSE:ABT | $152.22 Billion | $87.54 |
| #211 | Stryker Corporation | NYSE:SYK | $111.32 Billion | $290.88 |
| #229 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | XETRA:2M6 | $101.71 Billion | €67.76 |
Somnomed Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Somnomed Ltd's market cap moved from $335.65 Million to $ 94.56 Million, with a yearly change of -10.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$94.56 Million | -21.04% |
| 2025 | AU$119.75 Million | +67.93% |
| 2024 | AU$71.31 Million | -8.00% |
| 2023 | AU$77.51 Million | -59.47% |
| 2022 | AU$191.24 Million | -45.11% |
| 2021 | AU$348.38 Million | +11.91% |
| 2020 | AU$311.32 Million | -16.51% |
| 2019 | AU$372.89 Million | +60.11% |
| 2018 | AU$232.90 Million | -49.70% |
| 2017 | AU$463.00 Million | -5.21% |
| 2016 | AU$488.44 Million | +45.52% |
| 2015 | AU$335.65 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of Somnomed Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $94.56 Million USD |
| MoneyControl | $94.56 Million USD |
| MarketWatch | $94.56 Million USD |
| marketcap.company | $94.56 Million USD |
| Reuters | $94.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Somnomed Ltd
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product desig… Read more